U-Blot® Research Grade VipalanebartCat. No. WA3784Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade VipalanebartCat. No. WA3784
U-Blot® Research Grade VimekofuspCat. No. WA3783
U-Blot® Research Grade VilobelimabCat. No. WA3782
U-Blot® Research Grade VilastobartCat. No. WA3781
U-Blot® Research Grade VilamakitugCat. No. WA3780
U-Blot® Research Grade VibostolimabCat. No. WA3779
U-Blot® Research Grade VibecotamabCat. No. WA3778
U-Blot® Research Grade VevoctadekinCat. No. WA3777
U-Blot® Research Grade VesencumabCat. No. WA3776
U-Blot® Research Grade VerzistobartCat. No. WA3775
U-Blot® Research Grade verenafusp alfaCat. No. WA3774
U-Blot® Research Grade VerekitugCat. No. WA3773